Changes in Securities. In the event of changes in the outstanding Series E-5 Preferred or Common Stock of the Company by reason of stock dividends, splits, recapitalizations, reclassifications, combinations or exchanges of shares, separations,
Appears in 1 contract
Changes in Securities. In the event of changes in the outstanding Series E-5 Preferred or Common Stock of the Company by reason of stock dividends, splits, recapitalizations, reclassifications, combinations or exchanges of shares, separations,, reorganizations, consolidation, merger, liquidations, or the like, the number and class of shares available under the Warrant in the aggregate and the Exercise Price shall be correspondingly adjusted to give the Holder of the Warrant, on exercise for the same aggregate Exercise Price, the
Appears in 1 contract
Sources: Loan and Lease Agreement (Revance Therapeutics, Inc.)